Pulmonary surfactant

From WikiMD.org
Jump to navigation Jump to search

Pulmonary Surfactant

Pulmonary surfactant (pronounced: puhl-MON-uh-ree SUR-fak-tant) is a complex mixture of lipids and proteins that is secreted into the alveolar space by Type II alveolar cells. Its main function is to reduce the surface tension at the air/liquid interface in the lungs, thus preventing the alveoli from collapsing at the end of expiration.

Etymology

The term "pulmonary surfactant" is derived from the Latin pulmonarius (meaning "of the lungs") and the English word "surfactant" which is a portmanteau of "surface active agent".

Composition

Pulmonary surfactant is composed primarily of phospholipids (about 80%), the most important of which is Dipalmitoylphosphatidylcholine (DPPC). The remaining 20% is made up of other lipids and proteins, including surfactant proteins A, B, C, and D (SP-A, SP-B, SP-C, SP-D).

Function

The main function of pulmonary surfactant is to lower the surface tension at the air/liquid interface within the alveoli. This prevents the alveoli from collapsing at the end of expiration and thus maintains the patency of the alveoli. It also contributes to the host defense mechanisms of the lungs by opsonizing inhaled pathogens and facilitating their clearance by alveolar macrophages.

Clinical Significance

Deficiency of pulmonary surfactant in premature infants leads to Respiratory distress syndrome (RDS), also known as hyaline membrane disease. This condition can be treated with exogenous surfactant therapy. Mutations in the genes encoding the surfactant proteins can lead to various forms of interstitial lung disease.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski